logo
12:29 May 26

Kopran Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
193.12
+4.64 (+2.46%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Kopran Ltd. Financials

Kopran Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
193.12
+4.64 (+2.46%)
12:29 May 26
Quality
image/svg+xml

55/100
High Financial Strength

Valuation
image/svg+xml

44/100
Mid Valuation

Technical

60/100
Technically Moderately Bullish

Strength

12

Weakness

7

Opportunity

1

Threats

0

4.85 %

ROE %

2.83 %

ROA %

5.33

EPS

109.82

BVPS

3.77 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
477.52 550.99 614.59 629.6 681.42
Operating Expenses +
390.13 499.2 540.18 556.71 619.47
Raw Material
300.56 345.95 400.88 410.66 434.92
Increase Decrease in Cost
-29.19 12.62 1.06 -6.04 4.1
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
43.27 49.95 52.28 60.54 65.21
Miscellaneous Expenses
81.95 139.36 98.02 110.87 122.72
Operating Profit
87.39 51.79 74.41 72.89 61.95
Other Income
10.6 3.06 14.61 3.98 0.35
Depreciation
11.1 12.71 12.89 15.59 17.47
Interest
5.12 6.08 8.59 9.34 10.47
Profit before tax and exceptio..
81.78 36.07 67.54 51.95 34.36
Exceptional Items
0 0 0 0 0
PBT
81.78 36.07 67.54 51.95 34.36
Provision for Taxation
20.75 8.83 16.59 13.4 8.62
Net Profit
61.03 27.23 50.96 38.55 25.73
NET Profit after MI
61.03 27.23 50.96 38.55 25.73
EPS
13.77 5.65 10.57 7.99 5.33
Operating Profit Margin (%)
18.3 9.4 12.11 11.58 9.09
Net Profit Margin (%)
12.78 4.94 8.29 6.12 3.78

Kopran Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: